NIAID Grant for Vaccine Technology Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is offering a grant for the development of vaccine technologies. The grant aims to support projects focused on enhancing vaccine effectiveness and simplifying vaccine delivery during disease outbreaks. Applicants must include a Product Development Strategy and show significant involvement from a commercial partner. The closing date for applications is June 26, 2012.

Opportunity ID: 141893

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	RFA-AI-12-014
Funding Opportunity Title::	Partnerships for Development of Vaccine Technologies (R01)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Feb 01, 2012
Last Updated Date::
Original Closing Date for Applications::	Jun 26, 2012
Current Closing Date for Applications::	Jun 26, 2012
Archive Date::	Jul 27, 2012
Estimated Total Program Funding::	$ 9,300,000
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

Independent school districts

Additional Information on Eligibility::

Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites research applications for projects focused on preclinical development of candidate technologies (including adjuvants) that would improve vaccine effectiveness and/or simplify vaccine delivery to patient populations during a natural outbreak of an infectious disease or following the intentional release of an infectious agent. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:
Competition ID:	ADOBE-FORMS-B2
Competition Title:	ADOBE-FORMS-B2
Opportunity Package ID:	PKG00095614
Opening Date:	May 26, 2012
Closing Date:	Jun 26, 2012
Agency Contact Information::	Grants Info
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research And Related Other Project Information [V1.3] Research And Related Senior/Key Person Profile (Expanded) [V1.2] PHS 398 Cover Page Supplement [V1.4] PHS 398 Research Plan [V1.3] PHS 398 Checklist [V1.3]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] PHS 398 Modular Budget [V1.2] Research & Related Budget [V1.1] PHS Cover Letter [V1.2]